13220.00
-1.50%
Motilal Oswal
23 October 2019 While P&G; Hygiene and Healthcare (P&GHH;)s operations in 3QFY20 were affected by the COVID-19-led lockdown, its ability to arrest decline in profitability is encouraging. We believe the companys portfolio is highly resilient and would bounce back once normalcy returns. Long-term prospects remain attractive on account of strong moats. INR7.1b), with EBITDA decreasing 3.6% YoY to INR1.4b (est. INR1.4b) and PBT coming in flat YoY at INR1.4b (est.
Motilal Oswal decreased Neutral price target of Procter & Gamble Hygiene & Healthcare Ltd. to 15000.0 on 12 Jun, 2025.
More from Procter & Gamble Hygiene & Healthcare Ltd.
Recommended